Rajinder (@rajinder) 's Twitter Profile
Rajinder

@rajinder

Cardiologist. Interested in all things heart failure and pulmonary hypertension. Retweets ≠︎ endorsements.

ID: 14213190

calendar_today25-03-2008 04:28:27

10,10K Tweet

760 Takipçi

1,1K Takip Edilen

Ahmed Bennis (@drbennisahmed) 's Twitter Profile Photo

Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes In patients with HFrEF and COPD, beta-blocker use was associated with lower risk of cardiovascular

Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes

In patients with HFrEF and COPD, beta-blocker use was associated with lower risk of cardiovascular
Bruno R. Thal (@brunoraphaeldd) 's Twitter Profile Photo

🚨 Our new paper is out! We validated a pressure-based method to reconstruct RV PV loops from routine RHC. ✅ Agreement with conductance & 3D echo ✅ Reliable SW, contractility & afterload 🔗 pv-loop-generator.onrender.com jhltonline.org/article/S1053-…

🚨 Our new paper is out!
We validated a pressure-based method to reconstruct RV PV loops from routine RHC.
✅ Agreement with conductance & 3D echo
✅ Reliable SW, contractility & afterload
🔗 pv-loop-generator.onrender.com

jhltonline.org/article/S1053-…
Dr Rob 🫀🩺 🇦🇺 (@drhungo) 's Twitter Profile Photo

🧬🫀 The CARDIA study Shows that cumulative exposure to apoB & LDL particles in young adults strongly predicts later ASCVD. 👉 No “safe” LDL threshold identified - risk keeps falling the lower & longer LDL/apoB is controlled. Early prevention = lifelong protection. 🔗

🧬🫀 The CARDIA study 

Shows that cumulative exposure to apoB & LDL particles in young adults strongly predicts later ASCVD.

👉 No “safe” LDL threshold identified - risk keeps falling the lower & longer LDL/apoB is controlled.

Early prevention = lifelong protection.

🔗
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Patients w/ PVCs in the first 6 months after #epAblation for PAF are at higher risk for recurrent atrial arrhythmia. Whether PVCs themselves trigger atrial arrhythmias, or common underlying mechanisms trigger both, remains uncertain. jacc.org/doi/10.1016/j.… #JACCCEP Vivek Y. Reddy

Patients w/ PVCs in the first 6 months after #epAblation for PAF are at higher risk for recurrent atrial arrhythmia. Whether PVCs themselves trigger atrial arrhythmias, or common underlying mechanisms trigger both, remains uncertain. jacc.org/doi/10.1016/j.… #JACCCEP <a href="/VivekReddyMD/">Vivek Y. Reddy</a>
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

In this state-of-the-art review, the authors summarize current antithrombotic strategies for patients undergoing complex PCI and discuss evidence from randomized clinical trials evaluating these regimens in this context. eurointervention.pcronline.com/article/antith…

In this state-of-the-art review, the authors summarize current antithrombotic strategies for patients undergoing complex PCI and discuss evidence from randomized clinical trials evaluating these regimens in this context. eurointervention.pcronline.com/article/antith…
Dr Rob 🫀🩺 🇦🇺 (@drhungo) 's Twitter Profile Photo

🔺 Triglycerides: The Hidden Residual Risk in CVD 🫀💥 📊 In 9,436 pts with established CVD (9y FU), elevated TGs = ↑ recurrent events, CV death & mortality. ⚠️ TG risk persisted despite reaching LDL-C/non-HDL-C targets & across LLT intensity. 👉 TRLs are key drivers of

🔺 Triglycerides: The Hidden Residual Risk in CVD 🫀💥

📊 In 9,436 pts with established CVD (9y FU), elevated TGs = ↑ recurrent events, CV death &amp; mortality.

⚠️ TG risk persisted despite reaching LDL-C/non-HDL-C targets &amp; across LLT intensity.

👉 TRLs are key drivers of
Mohammad Keykhaei, MD, MPH (@m_keykhaei) 's Twitter Profile Photo

What a phenomenal start to #UCLAHF with the one & only Gregg Fonarow MD HFpEF/HFmrEF: 3 pillars of proven therapy ➡️ SGLT2i ➡️ nsMRA ➡️ GLP1/GLP1-GIP RA Start all 3 definitively proven disease-modifying drugs without delay, or in rapid sequence. Department of Medicine at UCLA Health UCLA Cardiology Fellowship UCLA Internal Medicine Chief Residents

What a phenomenal start to #UCLAHF with the one &amp; only <a href="/gcfmd/">Gregg Fonarow MD</a> 
HFpEF/HFmrEF: 3 pillars of proven therapy
➡️ SGLT2i
➡️ nsMRA
➡️ GLP1/GLP1-GIP RA
Start all 3 definitively proven disease-modifying drugs without delay, or in rapid sequence. <a href="/DOM_UCLA/">Department of Medicine at UCLA Health</a> <a href="/uclaCVfellows/">UCLA Cardiology Fellowship</a> <a href="/uclaimchiefs/">UCLA Internal Medicine Chief Residents</a>
Edgardo Alania (@ed_alania) 's Twitter Profile Photo

🔴 10 Issues for the Clinician in Tricuspid Regurgitation Evaluation & Management: 2025 ACC Expert Consensus Decision Pathway: A Report JACC Journals #Cardiology #CardioEd #Echofirst #FOAMed

🔴 10 Issues for the Clinician in Tricuspid Regurgitation Evaluation &amp; Management: 2025 ACC Expert Consensus Decision Pathway: A Report <a href="/JACCJournals/">JACC Journals</a> #Cardiology #CardioEd #Echofirst #FOAMed
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Nonatherothrombotic causes of #cvMI events, especially spontaneous coronary artery dissection, were more common in younger women than younger men, according to a community-based study published in #JACC. Read the journal scan for more ➡️ bit.ly/3KjOvn1 #HeartFailure

Nonatherothrombotic causes of #cvMI events, especially spontaneous coronary artery dissection, were more common in younger women than younger men, according to a community-based study published in #JACC.

Read the journal scan for more ➡️ bit.ly/3KjOvn1 #HeartFailure
Marina Saadi (@saadi_marina) 's Twitter Profile Photo

🚨Modified VExUS: A Dynamic Tool to Predict Mortality in Acute Decompensated Heart Failure - is out in JASE! 🔎 ΔVExUS ≥ 1 in 72h linked to better decongestion & lower mortality ⏳ Download here (limited time) 👉 kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

🚨Modified VExUS: A Dynamic Tool to Predict Mortality in Acute Decompensated Heart Failure - is out in JASE!

🔎 ΔVExUS ≥ 1 in 72h linked to better decongestion &amp; lower mortality

⏳ Download here (limited time)
👉 kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
JAHA (@jaha_aha) 's Twitter Profile Photo

Low-level albuminuria predicts risk of 💔#HeartFailure, 🧠#stroke, 🩸bleeding, and ☠️ death in #AFib. Read more in this linked administrative database study. #AHAJournals Husam Abdel-Qadir Sunnybrook Health Sciences Centre Women's College Hospital Peter Munk Cardiac Centre ICES ahajrnls.org/4mvMFN7

Low-level albuminuria predicts risk of 💔#HeartFailure, 🧠#stroke, 🩸bleeding, and ☠️ death in #AFib.

Read more in this linked administrative database study. #AHAJournals <a href="/husam247/">Husam Abdel-Qadir</a> <a href="/Sunnybrook/">Sunnybrook Health Sciences Centre</a> <a href="/WCHospital/">Women's College Hospital</a> <a href="/PMunkCardiacCtr/">Peter Munk Cardiac Centre</a> <a href="/ICESOntario/">ICES</a> ahajrnls.org/4mvMFN7
Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

“We highlight that functional capacity is yet another domain in which HF imposes a greater morbidity burden than cancer” Functional Limitations in Heart Failure and Cancer: An Analysis of the... sciencedirect.com/science/articl… Journal of Cardiac Failure JCF Intersections HFSA Sadiya Khan Eric H Yang, MD

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

I wouldn’t exactly call myself a black belt in beta-blockers, but with all this talk of superiority, "non-superiority," and "non-non-inferiority," it’s really enough to get confused. If I interpret correctly the avalanche of trials from the past year, accompanied by the

I wouldn’t exactly call myself a black belt in beta-blockers, but with all this talk of superiority, "non-superiority," and "non-non-inferiority," it’s really enough to get confused. If I interpret correctly the avalanche of trials from the past year, accompanied by the